197 related articles for article (PubMed ID: 33976347)
21. Histopathological patterns of thyroid disease in Al-Madinah region of Saudi Arabia.
Albasri A; Sawaf Z; Hussainy AS; Alhujaily A
Asian Pac J Cancer Prev; 2014; 15(14):5565-70. PubMed ID: 25081665
[TBL] [Abstract][Full Text] [Related]
22. Analysis of DNA mismatch repair gene expression and mutations in thyroid tumours.
Ruschenburg I; Vollheim B; Stachura J; Cordon-Cardo C; Korabiowska M
Anticancer Res; 2006; 26(3A):2107-12. PubMed ID: 16827152
[TBL] [Abstract][Full Text] [Related]
23. Association of tuberculous thyroiditis and papillary carcinoma of the thyroid: a rare coincidence.
Errami N; Benjellounb A; Hemmaouia B; Nadoura K; Benariba F
Pan Afr Med J; 2014; 19():118. PubMed ID: 25745526
[TBL] [Abstract][Full Text] [Related]
24. Expression of obestatin and ghrelin in papillary thyroid carcinoma.
Karaoglu A; Aydin S; Dagli AF; Cummings DE; Ozercan IH; Canatan H; Ozkan Y
Mol Cell Biochem; 2009 Mar; 323(1-2):113-8. PubMed ID: 19039650
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of AgNOR staining in thyroid cytology.
Shechtman L; Koren R; Horowitz A; Shechtman I; Halpern M; Gal R
Anal Quant Cytol Histol; 1998 Jun; 20(3):187-91. PubMed ID: 9642445
[TBL] [Abstract][Full Text] [Related]
26. The absence of CD56 expression can differentiate papillary thyroid carcinoma from other thyroid lesions.
Golu I; Vlad MM; Dema A; Moleriu LC; Tudor A; Iacob M; Popa O; Cornianu M
Indian J Pathol Microbiol; 2017; 60(2):161-166. PubMed ID: 28631628
[TBL] [Abstract][Full Text] [Related]
27. Histopathological findings in goiter: A review of 624 thyroidectomies.
Qureshi IA; Khabaz MN; Baig M; Begum B; Abdelrehaman AS; Hussain MB
Neuro Endocrinol Lett; 2015; 36(1):48-52. PubMed ID: 25789588
[TBL] [Abstract][Full Text] [Related]
28. Galectin-3 immunostaining in cytological and histopathological diagnosis of thyroid lesions.
Aiad HA; Kandil MA; Asaad NY; El-Kased AM; El-Goday SF
J Egypt Natl Canc Inst; 2008 Mar; 20(1):36-46. PubMed ID: 19847280
[TBL] [Abstract][Full Text] [Related]
29. [The value of ACR-TIRADS and C-TIRADS in the diagnosis of nodular Hashimoto thyroiditis and papillary thyroid carcinoma with Hashimoto thyroiditis].
Li C; Wen D; Lu H; Chen Y; Liu X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jun; 36(6):447-452. PubMed ID: 35822363
[No Abstract] [Full Text] [Related]
30. Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter.
Hu S; Zhang G; Xu J; Zhu X; Lu X; Jiang L; Wang Q; Hou X; Cao J; Ge M
Clin Lab; 2014; 60(12):2031-7. PubMed ID: 25651738
[TBL] [Abstract][Full Text] [Related]
31. Significance of IMP3, nucleophosmin, and Ki-67 expression in papillary thyroid carcinoma.
Yorukoglu A; Yalcin N; Avci A; Cakalagaoglu F; Yaylali G; Akin F; Haciyanli M; Ozden A
Int J Surg Pathol; 2015 Feb; 23(1):5-12. PubMed ID: 25389240
[TBL] [Abstract][Full Text] [Related]
32. Significance of AgNORs and ki-67 proliferative markers in differential diagnosis of thyroid lesions.
Aiad HA; Bashandy MA; Abdou AG; Zahran AA
Pathol Oncol Res; 2013 Apr; 19(2):167-75. PubMed ID: 23055017
[TBL] [Abstract][Full Text] [Related]
33. Correlation of MLH1 and MGMT expression and promoter methylation with genomic instability in patients with thyroid carcinoma.
Santos JC; Bastos AU; Cerutti JM; Ribeiro ML
BMC Cancer; 2013 Feb; 13():79. PubMed ID: 23414134
[TBL] [Abstract][Full Text] [Related]
34. Role of nuclear grooves in the diagnosis of papillary thyroid carcinoma. A quantitative assessment on fine needle aspiration smears.
Francis IM; Das DK; Sheikh ZA; Sharma PN; Gupta SK
Acta Cytol; 1995; 39(3):409-15. PubMed ID: 7539202
[TBL] [Abstract][Full Text] [Related]
35. [Differential protein expressions in papillary thyroid carcinoma patients with or without Hashimoto's thyroiditis].
Lu HZ; Zhang N; Liu W; Zhu XY; Qi D; Wang Y; Liu XY; Li ZJ
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):463-468. PubMed ID: 32575941
[No Abstract] [Full Text] [Related]
36. Follicular nodules (Thy3) of the thyroid: is total thyroidectomy the best option?
Calò PG; Medas F; Santa Cruz R; Podda F; Erdas E; Pisano G; Nicolosi A
BMC Surg; 2014 Mar; 14():12. PubMed ID: 24597765
[TBL] [Abstract][Full Text] [Related]
37. Expression of hepatocyte growth factor in Hashimoto's thyroiditis with nodular lesions.
Ruggeri RM; Sciacchitano S; Trimarchi F; Barresi G; Trovato M
Eur J Histochem; 2007; 51(3):193-8. PubMed ID: 17921114
[TBL] [Abstract][Full Text] [Related]
38. Likelihood ratio-based differentiation of nodular Hashimoto thyroiditis and papillary thyroid carcinoma in patients with sonographically evident diffuse hashimoto thyroiditis: preliminary study.
Wang L; Xia Y; Jiang YX; Dai Q; Li XY
J Ultrasound Med; 2012 Nov; 31(11):1767-75. PubMed ID: 23091247
[TBL] [Abstract][Full Text] [Related]
39. Proliferative activity of papillary carcinoma and benign papillary hyperplasia of thyroid follicular cells.
Dziecioł J; Lemancewicz D; Lebkowska U; Augustynowicz A; Dadan J; Klim B; Małdyk J
Folia Histochem Cytobiol; 2002; 40(2):201-2. PubMed ID: 12056645
[TBL] [Abstract][Full Text] [Related]
40. The association between thyroid carcinoma and Hashimoto's thyroiditis: the ultrasonographic and histopathologic characteristics of malignant nodules.
Gul K; Dirikoc A; Kiyak G; Ersoy PE; Ugras NS; Ersoy R; Cakir B
Thyroid; 2010 Aug; 20(8):873-8. PubMed ID: 20677997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
